Krystal Biotech buy Chardan Capital
Start price
20.02.25
/
50%
€172.25
Target price
20.02.26
€208.60
Performance (%)
-19.30%
Price
07:32
€139.00
Summary
This prediction is currently active. The prediction for Krystal Biotech disappoints with a performance of -19.30%. This prediction currently runs until 20.02.26. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | 5.830% | 5.830% |
| iShares Core DAX® | 1.218% | -2.761% |
| iShares Nasdaq 100 | 1.942% | 4.161% |
| iShares Nikkei 225® | 1.286% | 4.232% |
| iShares S&P 500 | 1.289% | 2.565% |
Comments by Chardan_Capital for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its price target raised by analysts at Chardan Capital from $212.00 to $218.00. They now have a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat